Css LLC Bellus Health Inc. Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.95 - $12.0 $155,730 - $208,800	-17,400 Reduced 38.85%	27,385 $288,000
Q2 2022 Aug 15, 2022	SELL	$6.46 - $10.02 $41,001 - $63,596	-6,347 Reduced 12.41%	44,785 $414,000
Q1 2022 May 16, 2022	BUY	$5.56 - $7.99 $242,971 - $349,163	43,700 Added 588.0%	51,132 $352,000
Q4 2021 Feb 14, 2022	SELL	$5.26 - $8.3 $211,452 - $333,660	-40,200 Reduced 84.4%	7,432 $60,000
Q3 2021 Nov 15, 2021	BUY	$2.7 - $6.64 $128,606 - $316,276	47,632 New	47,632 $292,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.